BIOTEST ApS: Financial statements 2019
CVR: 26736994
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
BIOTEST ApS (CVR 26736994) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 78,509 and a net result of DKK 263,140 compared with DKK -125,941 the year before. Equity in the 2019 report amounted to DKK 1,337,082. The solvency ratio was 82.3%.
- Gross Profit
- DKK 78,509
- Profit/Loss
- DKK 263,140
- Equity
- DKK 1,337,082
- Total Assets
- DKK 1,624,613
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 79 t. | 263 t. | 1.3 mio. | - |
| 2018 | - | -61 t. | -126 t. | 1.2 mio. | - |
| 2017 | - | -63 t. | 75 t. | 1.4 mio. | - |
| 2016 | - | 210 t. | -113 t. | 1.4 mio. | - |
| 2015 | - | 154 t. | 292 t. | 1.7 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
BIOTEST ApS has published its annual report for 2018. Gross profit came to DKK -61,450, and the net result was DKK -125,941.
About BIOTEST ApS
BIOTEST ApS is a Danish company of the type Anpartsselskab based in Middelfart, founded in 2002. The company is registered under the industry Anden måling og teknisk analyse. The management consists of Pauli Lejf Kiel. The company is owned by Pauli Lejf Kiel. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK -54,968 and a net result of DKK -65,376 compared with DKK 100,748 the year before. Equity in the 2025 report amounted to DKK 1,035,290.